AAD 2022 Meeting Coverage

Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.

More AAD 2022 Video Coverage

Antonella Tosti, MD: The Role of Dermoscopy in Hair and Scalp Disorders
Dr. Tosti reviews the useful and accessible technique of dermoscopy, which she asserts every dermatologist should use regularly for assessing disorders and treatment outcomes concerning
Neal Bhatia, MD: Controversies in the Use of Antibiotics
Dr. Bhatia reviews his AAD 2022 presentation on wise antibiotic use in dermatology.
Ronald Prussick, MD, FRCPC: Comorbidities in Psoriasis
Dr. Prussick discusses the importance of recognizing and addressing the most common comorbidities in patients with psoriasis as part of their treatment.
Robert Sidbury, MD, MPH: Guidelines for the Management of Atopic Dermatitis
Dr. Sidbury directed the AAD 2022 session, “Translating Evidence into Practice: Atopic Dermatitis Guidelines.” Here, he provides an overview of the presentations delivered during this
Sonja Ständer, MD: Prurigo Nodularis
Dr. Ständer reviews her AAD 2022 presentation, which focused on prurigo nodularis; she discusses impacts on quality of life in patients with this inflammatory skin
Nada Elbuluk, MD: Acne and Rosacea in Skin of Color
Dr. Elbuluk discusses her AAD 2022 presentation, which touched on topics such as post-inflammatory hyperpigmentation and sun protection in patients of color with acne and
Susan Taylor, MD: Skin of Color Curriculum
Dr. Taylor discusses the gaps in dermatology education regarding skin of color and introduces the Skin of Color curriculum now available online at the AAD
Raj Chovatiya, MD, PhD: Financial Burdens of Polypharmacy Among Patients with Atopic Dermatitis
Dr. Chovatiya discusses his research that he presented at AAD 2022, which examined out-of-pocket costs for patients with AD using multiple drugs and over-the-counter products
Linda Stein Gold, MD: What’s New in Acne and Rosacea
Dr. Stein Gold provides an overview of her lectures from AAD 2022, which explored new treatments for acne and rosacea.

JCAD’s coverage of the 2022 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).